Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 62, 2002 - Issue 3
Submit an article Journal homepage
19
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components

M. N. Holten-Anderson The Finsen Laboratory, Rigshospitalet, Copenhagen; Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen, Denmark
,
N. Brunner The Finsen Laboratory, Rigshospitalet, Copenhagen; Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen, Denmark
,
I.J. Christensen The Finsen Laboratory, Rigshospitalet, Copenhagen; Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen, Denmark
,
V. Jensen The Finsen Laboratory, Rigshospitalet, Copenhagen; Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen, Denmark
&
H.J. Nielsen The Finsen Laboratory, Rigshospitalet, Copenhagen; Department of Surgical Gastroenterology, Hvidovre Hospital, Copenhagen, Denmark
Pages 223-230 | Published online: 08 Jul 2009

  • Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992; 216: 633-8.
  • Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg 2000; 87: 1553-62.
  • Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group. Scand J Gastroenterol 2000; 35: 212-7.
  • Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-7.
  • Blomberg J, Möller T, Olsson H, Andersen H, Jönsson M. Cancer morbidity in blood recipients-results of a cohort study. Eur J Cancer 1993; 29A:2101-5.
  • Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ. Transfusion history and cancer risk in older women. Ann Intern Med 1993; 119: 8-15.
  • Brandt L, Brandt J, Olsson H, Andersen H, Möller T. Blood transfusion as a risk factor for nonHodgkin lymphoma. Br J Cancer 1996; 73: 1148-51.
  • Cerhan JR, Wallace RB, Folsom AR, Potter JD, Sellers TA, Zheng W, Lutz CT. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst 1997; 89: 314-8.
  • Jeter EK, Spivey MA. Noninfectious complications of blood transfusion. Hematol Oncol Clin North Am 1995; 9: 187-204.
  • Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Møller-Nielsen C, Hanberg-Sørensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-6.
  • Gafter U, Kalechman Y, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992; 41: 143-8.
  • Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, mempel M, Eissner HJ, Schildberg FW. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342(8883): 1328-33.
  • Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6.
  • Nielsen HJ, Werther K, Mynster T, Brünner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999; 39: 1078-83.
  • Frewin DB, Jonsson JR, Head RJ, Russell WJ, Beal RW. Histamine levels in stored human blood. Transfusion 1984; 24: 502-4.
  • Nielsen HJ. Clinical impact of bioactive substances in blood components: implications for leucocyte filtration. Infusionsther transfusionsmed 1998; 25: 296-304.
  • Watson SA, Wilkinson LJ, Robertson JF, Hardcastle JD. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993; 34: 1091-6.
  • Bajou K, Noel A, Gerard RD, Masson V, Brünner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM. Absence of host plasminogen activator inhibitor 1 prevents cancers invasion and vascularization. Nat Med 1998; 4: 923-8.
  • Kwaan HC, Wang J, Svoboda K, Declerck PJ. Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis. Br J Cancer 2000; 82: 1702-8.
  • Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, Kaufman RJ, Wong GG, Temple PA, Leary AC, Brown EL. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985; 315: 768-71.
  • Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroidpotentiating activity. Nature 1985; 318: 66-9.
  • Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC. K562 cells produce and respond to human erythroid-potentiating activity. Blood 1988; 71: 1720-5.
  • Chester L, Golde DW, Bersch N, Johnson MD. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 1995; 86: 4506-15.
  • Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-I) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298: 29-32.
  • Li G, Fridman R, Kirn HR. Tissue inhibitor of metalloproteinases-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 1999; 59: 6267-75.
  • Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998; 102: 2002-10.
  • Guedez L, Courtemanch L, Stetler-Stevenson M. Tissue inhibitor of metalloproteinase (TIMP-1) induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood 1998; 92: 1342-9.
  • Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997; 89: 1708-15.
  • Goss KJH, Brown PD, Matrisian L. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis. Int J Cancer 1998; 78: 629-35.
  • Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, Brünner N, Stephens RW. Quantitation of TIMP-I in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer 1999; 80: 495-503.
  • Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N. High preoperative plasma tissue inhibitors of metalloproteinases-1 levels are associated with short survival of patients with colorectal cancer. Clin Can Res 2000; 6: 4292-99.
  • Cooper TW, Eisen AZ, Stricklin GP, Welgus HG. Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sei USA 1985; 82: 2779-83.
  • Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S, Overgaard J, Lilja H, Harris A, Murphy G, Brünner N. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Can Res 2002; [update?]
  • Luparello C, Avanzato G, Carella C, PucciMinafra I. Tissue inhibitor of metalloprotease (TIMP-1) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat 1999; 54: 235-44.
  • Hewitt RE, Brown KE, Corcoran M, StetlerStevenson WG. Increased expression of tissue inhibitor of metalloproteinases type 1 (TIMP-1) in a more tumorigenic colon cancer cell line. J Pathol 2000; 192: 455-9.
  • Welgus HG, Stricklin GP. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 1983; 258: 12259-64.
  • Edvardsen L, Taaning E, Dreier B, Christensen LD, Mynster T, Nielsen HJ. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates. Am J Hem 2001; 67: 157-62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.